Skip to content

Clinical trials

Phase 1/2 Melanoma trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 1/2 Country / region: Switzerland Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20101
20131
20151
20162
20181
20204
20212
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated3
Active, not recruiting2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
Novartis Pharmaceuticals4
Bristol-Myers Squibb1
Celgene1
Centre Hospitalier Universitaire Vaudois1
Cytos Biotechnology AG1
Immunophotonics, Inc.1
Incyte Biosciences International Sàrl1
Innovent Biologics (Suzhou) Co. Ltd.1
Medicenna Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma19
Neoplasms7
Carcinoma, Non-Small-Cell Lung3
Carcinoma, Renal Cell3
Neoplasm Metastasis3
Sarcoma3
Endometrial Neoplasms2
Ovarian Neoplasms2
Triple Negative Breast Neoplasms2
Basal Cell Carcinoma1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.